|
 |
FDA Approval Activities for this Drug…
Panretin (alitretinoin) Gel, 0.1%, Ligand NDA 20-886 2/2/99 2/5/99 2/5/99 6/16/99 Panretin Indication: Treatment of cutaneous lesions in patients with AIDS-related Kaposi's sarcoma.
For the most up-to-date approval information, please locate this API using the drug index. |
|
|